KREMS, Austria, February 23, 2011 /PRNewswire/ -- Natural Sciences, Law and Management

Unique in Austria, the master programme "Regulatory Affairs" at the IMC UAS Krems offers its students the opportunity to study all aspects of regulatory affairs at a superior academic level. Students acquire profound interdisciplinary knowledge in medicine, toxicology and pharmacology, as well as the necessary legal expertise. The courses are taught at a national, European and international level. The core areas cover the development, quality, efficacy and safety of pharmaceuticals and medical devices, the development of product information and the processing of approval procedures. The two-year master programme is offered in a part-time format with English as language of instruction. Due to the way it is organised (weekend modules), it is also ideal for students from neighbouring countries.

Need for Regulatory Affairs Managers on the Rise

Pharmaceutical companies are seeing an increased need for regulatory affairs managers. These internal advisers are essential to pharmaceutical companies and act as an interface between production facilities, marketing and management departments, and also function as an indispensable link between companies and approval authorities. Their work requires the greatest care and comprehensive interdisciplinary and cross-national knowledge.

Life Sciences at the IMC University of Applied Sciences Krems

In the area of Life Sciences, the IMC UAS has been offering the programme "Medical and Pharmaceutical Biotechnology" for eight years. This new high-quality and internationally oriented education programme for Regulatory Affairs Managers is yet another programme with strong focus on practical issues that opens the door to international career opportunities.

The master programme Regulatory Affairs starts for the first time in the winter semester 2011/12 and addresses academics with a background in natural science. For more information:

Contact: IMC University of Applied Sciences Krems Michaela Sabathiel Tel: +43(0)2732802-530


Wolfgang Schütt - Head of Medical and Pharmaceutical Biotechnology Department:, +43(0)2732-802-321